Perhaps more importantly, this study also identified a set of MTEX proteins, including ADAMTS13, CNTN1, F10, HSP90AB1, ITIH3, MSN, PDCD6IP, PLOD1, RPS6KA3, SGCE, THBS1, TUBB, and UBA52, whose levels discriminated patients with MM who had PD from those who were NED/SD after therapy. This evidence concerns the gene PLOD1 and Miyoshi myopathy.